•] Shares AVROBIO, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 11th, 2018 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • New York
AVROBIO, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENTIndemnification Agreement • June 11th, 2018 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (“Agreement”) is made as of [ ],by and between AVROBIO, Inc., a Delaware corporation (the “Company”), and [Director] (“Indemnitee”).
AVROBIO, INC. EMPLOYMENT AGREEMENTEmployment Agreement • June 11th, 2018 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 8th day of June, 2018, between AVROBIO, Inc., a Delaware corporation (the “Company”), and Geoff MacKay (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”).
AVROBIO, INC. EMPLOYMENT AGREEMENTEmployment Agreement • June 11th, 2018 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 8th day of June, 2018, between AVROBIO, Inc., a Delaware corporation (the “Company”), and Katina Dorton (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”).
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF...License Agreement • June 11th, 2018 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Delaware
In consideration of the foregoing premises, the mutual promises and covenants set forth in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, BioMarin and AVROBIO hereby agree as follows:
